Related Attributes
Product details
Ponazuril Powder also known as Patrozulin. Coccidiosis is the most common and most invasive disease in poultry, the harm to the breeding industry is quite large, the main means of controlling the disease is still the main means of drug prevention and treatment.
Veterinary Medicine Ponazuril (also known as ponazuril, toltrazuril sulfone, toltrazuril sulfone, or toltrazuril sulfone) Ponazuril Raw Materials A new anticoccidial drug. (Ponazuril) is a metabolite of Toltrazuril (HY-B0175 ) with antiprotozoal activity.Ponazuril Raw Materials is a triazine anticoccidial agent developed for the prevention of coccidiosis in poultry.
Uses and functions of Ponazuril Powder.
This drug was approved by the US FDA in 2001 for the treatment of central mammalian diseases caused by coccidia such as Neosporahughsi and Sarcocystis. Compared with the previous Anticoccidial drug Totrizuril, the most important feature of Ponazuril is that it can cross the blood-brain barrier and directly kill the protozoa located in the brain and cerebrospinal fluid. protozoa, effectively relieving EPM symptoms.
Research shows that Patrozulin kills coccidia in animals without affecting the production of their own immunity, and with the enhancement of their own immunity, sick animals can gradually get rid of their dependence on drugs, while research shows that Patrozulin has a lower level of toxic effect than Toltrazulin. Therefore, Ponazuril has better prospects for market development and application.
Pharmacological Effects of Ponazuril Powder.
Toltrazuril sulfone (Ponazuril) is a metabolite of Toltrazuril (HY-B0175 ) with antiprotozoal activity.Toltrazuril sulfone is a triazine anticoccidial agent developed for the prevention of coccidiosis in poultry.
European Commission (EU) Regulation No 37/2010 of December 22, 2009 on the classification of pharmacologically active substances and their maximum residue limits in food of animal origin.
Production method of Ponazuril Powder.
Why choose us?
HRK Factory
About Shipping
Pharmaceutical Intermediate manufacturers
©2022 Xi'an Henrikang Biotech Co., Ltd.,